Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway-Reference-Cited by-同舟云学术

Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway

Published:2017-07-12 Issue:1 Volume:12 Page:
ISSN:1749-799X
Container-title:Journal of Orthopaedic Surgery and Research
language:en
Short-container-title:J Orthop Surg Res

Author:

Zhang Bin-Fei,Wang Peng-Fei,Cong Yu-Xuan,Lei Jin-Lai,Wang Hu,Huang Hai,Han Shuang,Zhuang Yan

Funder

the Foundation of Honghui Hospital

Natural Science Foundation of Shaanxi Province

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s13018-017-0614-z.pdf

Reference30 articles.

1. Gonzalez D. Crush syndrome. Crit Care Med. 2005;33(1 Suppl):S34–41.

2. Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med. 1991;324(20):1417–22.

3. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72.

4. Song XB, Zhou XL, Ni SZ, Yang GF, Tian SF, Shan J, Zhao Y, Shen J, Wang X. Early fluid resuscitation with hypertonic solution in a rat crush injury model. Shock. 2013;39(5):453–9.

5. Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med. 2006;354(10):1052–63.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing crush syndrome management: the potent role of Sodium zirconium cyclosilicate in early hyperkalemia intervention and survival enhancement in a rat model;Frontiers in Pharmacology;2024-05-13

2. DAMPs and radiation injury;Frontiers in Immunology;2024-01-25

3. Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies;Translational Research;2023-11

4. Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease;BMC Rheumatology;2023-08-07

5. Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-10-22